CareDx ups revenue guidance

 Second Quarter 2024 Financial Highlights

• Reported total revenue of $92.3 million, an increase of 31% year-over-year.
• Grew Testing Services volume to 43,700 tests, an increase of 17% year-over-year.
• Reported GAAP net loss of $1.4 million, non-GAAP net income of $13.6 million, and positive adjusted EBITDA of $12.9 million, a significant improvement from the second quarter 2023.
• Generated $18.9 million cash from operations. Ended the quarter with cash, cash equivalents, and marketable securities of approximately $228.9 million, with no debt.
• Raised 2024 guidance for annual revenue to $320 to $328 million and adjusted EBITDA to a gain of $9 to $15 million.

https://www.businesswire.com/news/home/20240731876395/en/